With two decades of experience spanning health care and pharmaceuticals, Chris Manfuso guides sales at Enovachem Pharmaceuticals. Living in South Carolina, Chris Manfuso spearheads business development and revenue generation efforts for a company that offers prepackaged hormones and wellness products to health care practitioners. These products are provided directly to patients, who no longer need to visit a pharmacy to obtain the hormones.
Enovachem’s EC-RX Kits, for compounding use only, include DHEA, Estradiol, Progesterone, Testosterone, and Testone CIK. The latter is a testosterone cypionate injection that delivers an endogenous androgen responsible for male sex organ growth. It is also responsible for secondary sex characteristics that include laryngeal enlargement and the thickening of the vocal cords, as well as male hair distribution.
As a testosterone ester, the Enovachem formulation is preserved in benzyl alcohol and cottonseed oil, and injected intramuscularly. This ensures that the injection, which can be administered at two-to-four-week intervals, is gradually absorbed from a lipid phase.
The primary uses of testosterone cypionate injections is in male replacement therapies associated with the patient’s lack of endogenous testosterone. Among the conditions treated are primary hypogonadism-testicular failure and pituitary-hypothalamic injury related to radiation, tumors, or trauma.
Chris Manfuso 